FDA Probes Child Death Linked to Drug for Blood Clotting Disorder

(MedPage Today) — The FDA said it has received postmarketing reports of neutralizing antibodies to ADAMTS13, including one death, in patients with congenital thrombotic thrombocytopenic purpura (cTTP) who were treated with the recombinant ADAMTS13…

Source link : https://www.medpagetoday.com/hematologyoncology/hematology/118655

Author :

Publish date : 2025-11-21 20:16:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

FDA Probes Child Death Linked to Drug for Blood Clotting Disorder

Telehealth-Based Cancer Trial; AI-Based Cancer Biomarkers; Myeloma Survival Landmark

Primary Hyperparathyroidism Tied to Long-Term Cardiometabolic Risks

Related Posts

Can Hope Prime the Immune System via Brain Reward Pathways?

CMA Funds Program to HELP International Physicians Practice

Early Antenatal Prediabetes Tied to Postpartum T2D

Revised Obesity Definition Reveals Hidden Cardiac Risk

This Drug Can Reduce Hot Flashes During Prostate Cancer Tx

Maternal Diabetes Tied to Epilepsy Risk in Kids

Can Hope Prime the Immune System via Brain Reward Pathways?

CMA Funds Program to HELP International Physicians Practice

Early Antenatal Prediabetes Tied to Postpartum T2D

Revised Obesity Definition Reveals Hidden Cardiac Risk

This Drug Can Reduce Hot Flashes During Prostate Cancer Tx

Maternal Diabetes Tied to Epilepsy Risk in Kids

Early Cow’s Milk Immunotherapy Is Safe in Children

No-one knows what to expect when you’re dying – but hospices helped me

Categories

Archives